EYLEA (aflibercept)

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.

About Bayer

Bayer AG is one of the world's largest pharmaceutical and life sciences companies, headquartered in Leverkusen, Germany. The company develops and commercializes innovative therapies across oncology, cardiology, ophthalmology, and hematology, while also maintaining leading positions in consumer health products and agricultural sciences. With operations in over 100 countries and approximately 100,000 employees globally, Bayer continues to focus on breakthrough innovations in health and nutrition.

Therapeutic Areas